 MADISON, Wis. , April 8, 2022 PRNewswire -- Exact Sciences Corp. Nasdaq: EXAS, a leader in advanced cancer diagnostics, today announced that the company plans to release its first quarter 2022 financial results after the close of the U.S. financial markets on April 26, 2022. 